VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts22102323
Avg. Estimate1.061.013.824.24
Low Estimate0.680.843.223.25
High Estimate1.311.194.15.31
Year Ago EPS0.610.761.953.82
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts20102323
Avg. Estimate818.73M837.14M2.99B3.52B
Low Estimate785.87M799.5M2.81B3.1B
High Estimate878.52M889.5M3.05B3.9B
Year Ago Sales622.63M638.88M2.17B2.99B
Sales Growth (year/est)31.50%31.00%37.40%18.00%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.0.530.630.751.02
EPS Actual0.610.760.941.09
Difference0.080.130.190.07
Surprise %15.10%20.60%25.30%6.90%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate1.061.013.824.24
7 Days Ago1.060.973.824.13
30 Days Ago1.061.013.824.27
60 Days Ago1.081.113.784.59
90 Days Ago1.081.153.774.7
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesVRTXIndustrySectorS&P 500
Current Qtr.73.80%N/AN/A0.48
Next Qtr.32.90%N/AN/A0.32
Current Year95.90%N/AN/A0.20
Next Year11.00%N/AN/A0.09
Next 5 Years (per annum)56.86%N/AN/A0.12
Past 5 Years (per annum)61.50%N/AN/AN/A